PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-90.38%
Negative revenue growth while CX stands at 2.46%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
28.82%
Gross profit growth above 1.5x CX's 2.56%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
38.02%
EBIT growth above 1.5x CX's 4.48%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
38.02%
Operating income growth above 1.5x CX's 4.48%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
166.26%
Net income growth above 1.5x CX's 15.32%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
156.25%
EPS growth above 1.5x CX's 13.79%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
146.67%
Diluted EPS growth above 1.5x CX's 13.79%. David Dodd would see if there's a robust moat protecting these shareholder gains.
1.70%
Share count expansion well above CX's 2.28%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
12.70%
Diluted share count expanding well above CX's 2.28%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-80.09%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-80.65%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-87.38%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
192.86%
Positive 5Y CAGR while CX is negative. John Neff might view this as a strong mid-term relative advantage.
57.69%
Positive short-term CAGR while CX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.